Skip to main navigation
Skip to search
Skip to main content
Press / Media
Is HBsAg loss an ideal end-point of oral antiviral therapy in chronic hepatitis B patients?
Keunhee Kang, Ji H.oon Kim
Department of Gastroenterology & Hepatology
Contribution to journal
Dive into the research topics of 'Is HBsAg loss an ideal end-point of oral antiviral therapy in chronic hepatitis B patients?'. Together they form a unique fingerprint.